Evidence map›Paper›PMID 36048148›Full record

ArticleActa crystallographica. Section D, Structural biology2022

CCP4 Cloud for structure determination and project management in macromolecular crystallography.

Eugene Krissinel, Andrey A Lebedev, Ville Uski, Charles B Ballard, Ronan M Keegan, Oleg Kovalevskiy, Robert A Nicholls, Navraj S Pannu, Pavol Skubák, John Berrisford and 23 more

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Article
  3. Structural insights into a putative BLF1-like deamidase from Methylomonas sp. Kb3.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Multicyclic D-Stereospecific Hydrolase Dimer With High Sustained Activity.Angewandte Chemie (International ed. in English) · 2026
    Article
  9. Article
  10. Structural insights intoInorganic chemistry frontiers · 2026
    Article
  11. Crystal structure of a cold-active arginase from Glaciozyma antarctica.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  12. Crystallization and 1.6 Å resolution crystal structure of an acylated GLP-1/GIP analogue peptide.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  13. Molecular analysis of 3D domain swapping in the acylphosphatase from Escherichia coli.Acta crystallographica. Section D, Structural biology · 2026
    Article
  14. Article
  15. Article
  16. A new crystal form of the DNA-free full-length XPD helicase from Thermoplasma acidophilum.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  17. Crystal structure of a tRNA acceptor-stem mimic at 1.94 Å resolution.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Eugene KrissinelScientific Computing Department, Science and Technology Facilities Council UK, Didcot OX11 0FA, United Kingdom.
Andrey A LebedevScientific Computing Department, Science and Technology Facilities Council UK, Didcot OX11 0FA, United Kingdom.ORCID 0000-0003-2261-0945
Ville UskiScientific Computing Department, Science and Technology Facilities Council UK, Didcot OX11 0FA, United Kingdom.ORCID 0000-0002-1615-4798
Charles B BallardScientific Computing Department, Science and Technology Facilities Council UK, Didcot OX11 0FA, United Kingdom.
Ronan M KeeganScientific Computing Department, Science and Technology Facilities Council UK, Didcot OX11 0FA, United Kingdom.
Oleg KovalevskiyScientific Computing Department, Science and Technology Facilities Council UK, Didcot OX11 0FA, United Kingdom.
Robert A NichollsStructural Studies Division, MRC Laboratory for Structural Biology, Cambridge CB2 0QH, United Kingdom.ORCID 0000-0002-8577-8617
Navraj S PannuLeiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Pavol SkubákLeiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0001-7254-8014
John BerrisfordEuropean Bioinformatics Institute, Hinxton CB9 1SD, United Kingdom.
Maria FandoInstitute of Protein Research, Pushchino 142290, Russian Federation.
Bernhard LohkampDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.ORCID 0000-0002-5646-2090
Marcin WojdyrGlobal Phasing Limited, Sheraton House, Castle Park, Cambridge CB3 0AX, United Kingdom.ORCID 0000-0003-3980-4092
Adam J SimpkinInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
Jens M H ThomasInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
Christopher OliverSchool of Physics and Astronomy, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Clemens VonrheinGlobal Phasing Limited, Sheraton House, Castle Park, Cambridge CB3 0AX, United Kingdom.
Grzegorz ChojnowskiEuropean Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22607 Hamburg, Germany.ORCID 0000-0002-3796-8352
Arnaud BasleNewcastle University Biosciences Institute Medical School, Newcastle upon Tyne NE2 4AX, United Kingdom.ORCID 0000-0002-4899-3086
Andrew PurkissStructural Biology Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom.ORCID 0000-0002-5931-3509
Michail N IsupovBiosciences, University of Exeter, Stocker Road, Exeter EX4 4QD, United Kingdom.ORCID 0000-0001-6842-4289
Stuart McNicholasYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.
Edward LoweDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.
Josep TriviñoCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Barcelona Science Park, Helix Building, Baldiri Reixac 15, 08028 Barcelona, Spain.
Kevin CowtanYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.ORCID 0000-0002-0189-1437
Jon AgirreYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, United Kingdom.ORCID 0000-0002-1086-0253
Daniel J RigdenInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.ORCID 0000-0002-7565-8937
Isabel UsonCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Barcelona Science Park, Helix Building, Baldiri Reixac 15, 08028 Barcelona, Spain.
Victor LamzinEuropean Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 85, 22607 Hamburg, Germany.ORCID 0000-0002-6058-7793
Ivo TewsBiological Sciences, Institute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.ORCID 0000-0002-4704-1139
Gerard BricogneGlobal Phasing Limited, Sheraton House, Castle Park, Cambridge CB3 0AX, United Kingdom.
Andrew G W LeslieStructural Studies Division, MRC Laboratory for Structural Biology, Cambridge CB2 0QH, United Kingdom.ORCID 0000-0002-5229-3656
David G BrownServier Research Institute in Croissy-sur-Seine, 125 Chemin de Ronde, 78290 Croissy, France.

Funding

Biotechnology and Biological Sciences Research Council BBF020384/1Biotechnology and Biological Sciences Research Council BB/L007037/1Biotechnology and Biological Sciences Research Council BB/S005099/1Biotechnology and Biological Sciences Research Council BB/S007040/1Biotechnology and Biological Sciences Research Council BB/S007083/1Biotechnology and Biological Sciences Research Council BB/S007105/1Medical Research Council MC_U105184325Medical Research Council MC_UP_A025_1012Nederlandse Wetenschappelijke Organisatie TKI 16219Röntgen-Ångström Cluster 349-2013-597
6 · The paper itself

Abstract

Nowadays, progress in the determination of three-dimensional macromolecular structures from diffraction images is achieved partly at the cost of increasing data volumes. This is due to the deployment of modern high-speed, high-resolution detectors, the increased complexity and variety of crystallographic software, the use of extensive databases and high-performance computing. This limits what can be accomplished with personal, offline, computing equipment in terms of both productivity and maintainability. There is also an issue of long-term data maintenance and availability of structure-solution projects as the links between experimental observations and the final results deposited in the PDB. In this article, CCP4 Cloud, a new front-end of the CCP4 software suite, is presented which mitigates these effects by providing an online, cloud-based environment for crystallographic computation. CCP4 Cloud was developed for the efficient delivery of computing power, database services and seamless integration with web resources. It provides a rich graphical user interface that allows project sharing and long-term storage for structure-solution projects, and can be linked to data-producing facilities. The system is distributed with the CCP4 software suite version 7.1 and higher, and an online publicly available instance of CCP4 Cloud is provided by CCP4.

Indexed as

Cloud ComputingSoftwareCrystallography, X-RayMacromolecular SubstancesMacromolecular SubstancesCCP4CCP4 Clouddata managementdistributed computingmacromolecular crystallographyproject management

Identifiers

PMID36048148
PMCPMC9435598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.